Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 1 Schemes (0.14%)
Foreign Institutions
Held by 100 Foreign Institutions (10.52%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
163 Million
(Quarterly Results - Jun 2026)
Net Profit:
27 Million
Pharmaceuticals & Biotechnology
ILS 1,539 Million ()
16.00
NA
0.06%
-0.25
8.94%
1.92
Footer loading






